Close Bookmark and Share This Page

Save to Browser Favorites / Bookmarks

Ask backflip blinklist BlogBookmark Bloglines BlogMarks Blogsvine BuddyMarks BUMPzee! CiteULike Connotea del.icio.us

Digg diigo DotNetKicks DropJack dzone Facebook Fark Faves Friendsite folkd.com Furl Google

Jamespot Jeqq Kaboodle kirtsy linkaGoGo LinkedIn Ma.gnolia Mister Wong Mixx MySpace Netvouz Newsvine

oneview OnlyWire PlugIM Propeller Reddit Segnalo Shoutwire Simpy Slashdot Surphace Sphinn Spurl

Squidoo StumbleUpon Technorati ThisNext Twitter Webride Windows Live Yahoo!

Email This to a Friend

  Link HTML: 

 Permalink: 

 If you like this then please subscribe to the RSS Feed.

Powered by Bookmarkify™

More »

View the full A chart at Wikinvest

Scientific instruments maker Agilent Technologies Inc. (A: News ) Friday reported a nine-fold rise in fourth-quarter profit, as revenue jumped 35% from last year and orders grew 32%. Adjusted earnings surpassed Wall Street estimates. Further, the company issued a robust outlook for the first quarter as well as full year.

The company’s net income surged to $232 million or $0.66 per share from $25 million or $0.07 per share in the year-ago quarter. Results in both years included items such as business divestitures and restructuring charges. The latest results also included a tax benefit and a one-time gain from the closure of pre-Agilent spin-off income tax audits.

Adjusted net income rose to $228 million or $0.65 per share from $111 million or $0.32 per share in the previous year. On average, 12 analysts polled by Thomson Reuters expected the company to earn $0.60 per share in the quarter. Analysts’ estimates typically exclude special items.

Net revenue rose to $1.576 billion from last year’s $1.167 billion. Adjusted for the acquisition of Varian Inc. and recent divestitures, revenue grew 26% from last year. Analysts expected revenues of $1.52 billion for the quarter.

Agilent completed the divestiture of its Network Services business on May 1, and later completed its $1.5 billion acquisition of scientific-equipment maker Varian, Inc. on May 14. Chemical Analysis revenues jumped 73% from last year, or 17% on an organic basis with applied markets reporting strong growth.

Life Sciences revenues jumped 35% and grew 17% on an organic basis. Academia and government markets, as well as pharmaceutical and biotech customers reported double-digit organic growth.

Regards,

Don